{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:31:15Z","timestamp":1793399475819,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82570972"],"award-info":[{"award-number":["82570972"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhengzhou Collaborative Innovation Project","award":["XTCX2023012"],"award-info":[{"award-number":["XTCX2023012"]}]},{"name":"Henan Provincial Natural Science Foundation Project","award":["242300421277"],"award-info":[{"award-number":["242300421277"]}]},{"name":"Henan Province young and middle-aged health science and technology innovation outstanding talent project","award":["YXKC2022034"],"award-info":[{"award-number":["YXKC2022034"]}]},{"name":"The Young Faculty Basic Research Training Program of Zhengzhou University","award":["JC22862035"],"award-info":[{"award-number":["JC22862035"]}],"id":[{"id":"https:\/\/ror.org\/04ypx8c21","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-03008-w","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:21:13Z","timestamp":1787556073000},"page":"3513-3530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mettl14-mediated m6A modification of lncRNA Gm2824 regulates GLP-1 secretion via the YBX1\/Foxa1 pathway in type 2 diabetic mice"],"prefix":"10.1007","volume":"49","author":[{"given":"Jiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"3008_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","volume":"24","author":"DJ Drucker","year":"2025","unstructured":"Drucker DJ (2025) GLP-1-based therapies for diabetes, obesity and beyond. Nat Rev Drug Discov 24:631\u2013650","journal-title":"Nat Rev Drug Discov"},{"key":"3008_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","volume":"400","author":"E Ahmad","year":"2022","unstructured":"Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ (2022) Type 2 diabetes. Lancet 400:1803\u20131820","journal-title":"Lancet"},{"key":"3008_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jama.2025.14392","volume":"334","author":"MJ Gonzalez-Rellan","year":"2025","unstructured":"Gonzalez-Rellan MJ, Drucker DJ (2025) New Molecules and Indications for GLP-1 Medicines. JAMA 334:1231\u20131234","journal-title":"JAMA"},{"key":"3008_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41574-024-00979-9","volume":"20","author":"S Ansari","year":"2024","unstructured":"Ansari S, Khoo B, Tan T (2024) Targeting the incretin system in obesity and type 2 diabetes mellitus. Nat Rev Endocrinol 20:447\u2013459","journal-title":"Nat Rev Endocrinol"},{"key":"3008_CR5","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1007\/s00125-025-06499-z","volume":"68","author":"B Yau","year":"2025","unstructured":"Yau B, Ghislain J, Kebede MA, Hughes J, Poitout V (2025) The role of the beta cell in type 2 diabetes: new findings from the last 5 years. Diabetologia 68:2092\u20132103","journal-title":"Diabetologia"},{"key":"3008_CR6","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/S0140-6736(25)01375-3","volume":"406","author":"J Deanfield","year":"2025","unstructured":"Deanfield J, Lincoff AM, Kahn SE, Emerson SS, Lingvay I, Scirica BM et al (2025) Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial. Lancet 406:2257\u20132268","journal-title":"Lancet"},{"key":"3008_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S2213-8587(25)00225-6","volume":"13","author":"I Lingvay","year":"2025","unstructured":"Lingvay I, Bergenheim SJ, Buse JB, Freitas P, Garvey WT, Harder-Lauridsen NM et al (2025) Once-weekly semaglutide 7\u00b72\u00a0mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial. Lancet Diabetes Endocrinol 13:935\u2013948","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3008_CR8","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2337\/dc13-2618","volume":"37","author":"A Ceriello","year":"2014","unstructured":"Ceriello A, Novials A, Canivell S, La Sala L, Pujadas G, Esposito K et al (2014) Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes. Diabetes Care 37:1938\u20131943","journal-title":"Diabetes Care"},{"key":"3008_CR9","doi-asserted-by":"publisher","first-page":"eady8048","DOI":"10.1126\/sciadv.ady8048","volume":"11","author":"C Cui","year":"2025","unstructured":"Cui C, Leander DC, Gray SM, El K, Chen A, Grimsrud PA et al (2025) \u03b1 cells use both PC1\/3 and PC2 to process proglucagon peptides and control insulin secretion. Sci Adv 11:eady8048","journal-title":"Sci Adv"},{"key":"3008_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41419-020-03366-0","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Zhao D, Ding CZ, Guo F, Wu LN, Huang FJ et al (2021) MicroRNA-194: a novel regulator of glucagon-like peptide-1 synthesis in intestinal L cells. Cell Death Dis 12:113","journal-title":"Cell Death Dis"},{"key":"3008_CR11","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1053\/j.gastro.2009.08.059","volume":"137","author":"DZ Ye","year":"2009","unstructured":"Ye DZ, Kaestner KH (2009) Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice. Gastroenterology 137:2052\u20132062","journal-title":"Gastroenterology"},{"key":"3008_CR12","doi-asserted-by":"publisher","first-page":"123355","DOI":"10.1016\/j.lfs.2024.123355","volume":"363","author":"L Yan","year":"2025","unstructured":"Yan L, Guo L (2025) The role and mechanism of m6A methylation in diabetic nephropathy. Life Sci 363:123355","journal-title":"Life Sci"},{"key":"3008_CR13","doi-asserted-by":"publisher","first-page":"1462146","DOI":"10.3389\/fendo.2024.1462146","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zou J, Zhou H (2024) N6-methyladenine RNA methylation epigenetic modification and diabetic microvascular complications. Front Endocrinol (Lausanne) 15:1462146","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3008_CR14","doi-asserted-by":"publisher","first-page":"116185","DOI":"10.1016\/j.biopha.2024.116185","volume":"171","author":"J Huang","year":"2024","unstructured":"Huang J, Yang F, Liu Y, Wang Y (2024) N6-methyladenosine RNA methylation in diabetic kidney disease. Biomed Pharmacother 171:116185","journal-title":"Biomed Pharmacother"},{"key":"3008_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41556-024-01368-0","volume":"26","author":"DF De Jesus","year":"2024","unstructured":"De Jesus DF, Zhang Z, Brown NK, Li X, Xiao L, Hu J et al (2024) Redox regulation of m(6)A methyltransferase METTL3 in \u03b2-cells controls the innate immune response in type 1 diabetes. Nat Cell Biol 26:421\u2013437","journal-title":"Nat Cell Biol"},{"key":"3008_CR16","doi-asserted-by":"publisher","first-page":"e10386","DOI":"10.1002\/advs.202410386","volume":"12","author":"M Wang","year":"2025","unstructured":"Wang M, Gao Z, Zhao R, Zhou P, Chen J, Zhang H et al (2025) METTL14-Mediated M(6)A Modification of LINC01094 Induces Glucose Metabolic Reprogramming in Breast Cancer by Recruiting the PKM2\/JMJD5 Complex. Adv Sci (Weinh) 12:e10386","journal-title":"Adv Sci (Weinh)"},{"key":"3008_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-024-01962-8","volume":"23","author":"T Jiang","year":"2024","unstructured":"Jiang T, Qi J, Xue Z, Liu B, Liu J, Hu Q et al (2024) The m(6)A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN. Mol Cancer 23:55","journal-title":"Mol Cancer"},{"key":"3008_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41574-022-00671-w","volume":"18","author":"C Ling","year":"2022","unstructured":"Ling C, Bacos K, R\u00f6nn T (2022) Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine? Nat Rev Endocrinol 18:433\u2013448","journal-title":"Nat Rev Endocrinol"},{"key":"3008_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41419-022-05348-w","volume":"13","author":"WH Guo","year":"2022","unstructured":"Guo WH, Guo Q, Liu YL, Yan DD, Jin L, Zhang R et al (2022) Mutated lncRNA increase the risk of type 2 diabetes by promoting \u03b2 cell dysfunction and insulin resistance. Cell Death Dis 13:904","journal-title":"Cell Death Dis"},{"key":"3008_CR20","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s42255-024-01036-5","volume":"6","author":"H Wang","year":"2024","unstructured":"Wang H, Wang J, Cui H, Fan C, Xue Y, Liu H et al (2024) Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy. Nat Metab 6:1161\u20131177","journal-title":"Nat Metab"},{"key":"3008_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C et al (2024) Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther 9:234","journal-title":"Signal Transduct Target Ther"},{"key":"3008_CR22","doi-asserted-by":"publisher","first-page":"102214","DOI":"10.1016\/j.xcrm.2025.102214","volume":"6","author":"MJ Gonzalez-Rellan","year":"2025","unstructured":"Gonzalez-Rellan MJ, Drucker DJ (2025) The expanding benefits of GLP-1 medicines. Cell Rep Med 6:102214","journal-title":"Cell Rep Med"},{"key":"3008_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41591-025-04124-5","volume":"32","author":"DJ Drucker","year":"2026","unstructured":"Drucker DJ (2026) The expanding landscape of GLP-1 medicines. Nat Med 32:47\u201357","journal-title":"Nat Med"},{"key":"3008_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41538-025-00445-4","volume":"9","author":"X Ye","year":"2025","unstructured":"Ye X, Chen W, Yan F, Zheng X, Tu P (2025) Cyanidin-3-O-glucoside enhances GLP-1 secretion via PPAR\u03b2\/\u03b4-\u03b2-catenin-TCF-4 pathway in type 2 diabetes mellitus. NPJ Sci Food 9:81","journal-title":"NPJ Sci Food"},{"key":"3008_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40618-025-02719-w","volume":"49","author":"G Rossi","year":"2026","unstructured":"Rossi G, Bucciarelli L, Cimino V, Fiorina P (2026) The role of the incretin GIP in inflammation. J Endocrinol Invest 49:255\u2013266","journal-title":"J Endocrinol Invest"},{"key":"3008_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41366-020-00694-1","volume":"45","author":"C Osinski","year":"2021","unstructured":"Osinski C, Le Gl\u00e9au L, Poitou C, de Toro-Martin J, Genser L, Fradet M et al (2021) Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity. Int J Obes (Lond) 45:170\u2013183","journal-title":"Int J Obes (Lond)"},{"key":"3008_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12943-023-01780-4","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wei J, Feng L, Li O, Huang L, Zhou S et al (2023) Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Mol Cancer 22:81","journal-title":"Mol Cancer"},{"key":"3008_CR28","doi-asserted-by":"publisher","first-page":"1635209","DOI":"10.3389\/fonc.2025.1635209","volume":"15","author":"X Zheng","year":"2025","unstructured":"Zheng X, Zeng F, Lei Y, Li Y, Deng J, Luo G et al (2025) YBX1: an RNA\/DNA-binding protein that affects disease progression. Front Oncol 15:1635209","journal-title":"Front Oncol"},{"key":"3008_CR29","doi-asserted-by":"publisher","first-page":"e2421155122","DOI":"10.1073\/pnas.2421155122","volume":"122","author":"RJ Dickmander","year":"2025","unstructured":"Dickmander RJ, Lenarcic EM, Sears JD, Hale AE, Moorman NJ (2025) RNA-targeted proteomics identifies YBX1 as critical for efficient HCMV mRNA translation. Proc Natl Acad Sci U S A 122:e2421155122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3008_CR30","doi-asserted-by":"publisher","first-page":"115324","DOI":"10.1016\/j.celrep.2025.115324","volume":"44","author":"F Liu","year":"2025","unstructured":"Liu F, Wang M, Gao S, Song G, Liu M, Li Y et al (2025) RNA m(5)C methylation mediated by Ybx1 ensures hematopoietic stem and progenitor cell expansion. Cell Rep 44:115324","journal-title":"Cell Rep"},{"key":"3008_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-biochem-062917-012708","volume":"89","author":"JL Rinn","year":"2020","unstructured":"Rinn JL, Chang HY (2020) Long Noncoding RNAs: Molecular Modalities to Organismal Functions. Annu Rev Biochem 89:283\u2013308","journal-title":"Annu Rev Biochem"},{"key":"3008_CR32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s42255-019-0089-9","volume":"1","author":"DF De Jesus","year":"2019","unstructured":"De Jesus DF, Zhang Z, Kahraman S, Brown NK, Chen M, Hu J et al (2019) m(6)A mRNA Methylation Regulates Human \u03b2-Cell Biology in Physiological States and in Type 2 Diabetes. Nat Metab 1:765\u2013774","journal-title":"Nat Metab"},{"key":"3008_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41467-024-55694-w","volume":"16","author":"L Xiao","year":"2025","unstructured":"Xiao L, De Jesus DF, Ju CW, Wei JB, Hu J, DiStefano-Forti A et al (2025) Divergent roles of m(6)A in orchestrating brown and white adipocyte transcriptomes and systemic metabolism. Nat Commun 16:533","journal-title":"Nat Commun"},{"key":"3008_CR34","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","volume":"36","author":"MB Nasr","year":"2024","unstructured":"Nasr MB, Usuelli V, Dellepiane S, Seelam AJ, Fiorentino TV, D\u2019Addio F et al (2024) Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule. Cell Metab 36:1302\u20131319 e1312","journal-title":"Cell Metab"},{"key":"3008_CR35","doi-asserted-by":"publisher","first-page":"E595","DOI":"10.1152\/ajpendo.00236.2023","volume":"325","author":"F Folli","year":"2023","unstructured":"Folli F, Finzi G, Manfrini R, Galli A, Casiraghi F, Centofanti L et al (2023) Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets. Am J Physiol Endocrinol Metab 325:E595\u2013e609","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3008_CR36","doi-asserted-by":"publisher","first-page":"e93091","DOI":"10.1172\/jci.insight.93091","volume":"4","author":"TV Fiorentino","year":"2019","unstructured":"Fiorentino TV, Casiraghi F, Davalli AM, Finzi G, La Rosa S, Higgins PB et al (2019) Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas. JCI Insight 4:e93091","journal-title":"JCI Insight"},{"key":"3008_CR37","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1186\/s12967-025-07331-3","volume":"23","author":"H Deng","year":"2025","unstructured":"Deng H, Liu Q, Gong Y, Qiu Y (2025) Regulation of m6A methylation in the immune microenvironment in the development of diabetes mellitus. J Transl Med 23:1308","journal-title":"J Transl Med"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03008-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03008-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03008-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:01:18Z","timestamp":1793397678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03008-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3008"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-03008-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee and conducted in accordance with the Guide for Care and Use of Laboratory Animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest to be declared.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}